SILEXION THERAPEUTICS CORP

Q2 2025 13F Holders

Symbol
SLXN
CUSIP
G1281K122
Type
Equity
Class
SHS NEW
Num filings
7
Total reported value, excl. options
$229 k
Manager Report Date Value ($000) Shares Option Type